HAGLROS, as a novel lncRNA, was first reported to promote the malignant phenotype of gastric cancer by sponging miR-100-5p to increase mTOR expression and interacting with mTORC1 components to activate the mTORC1 signalling pathway (13). This evidence concerns the gene MTOR and gastric cancer.